Skip to content

US · GLAS · DRUG MANUFACTURERS - SPECIALTY & GENERIC

Glass House Brands Inc (GLAS) intrinsic value and stock valuation

$7.97as of 2026-09-18 · Mkt cap 621.73M

Data updated · price as of 2026-09-18

IC valuationIntrinsic value, upside vs price and the fair-value band are available to Pro members.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

Glass House Brands Inc DCF and intrinsic value

InvestorsCraft values GLAS with the Chepakovich two-stage DCF model. How the model works · Run your own DCF prefilled from GLAS’s statements →

Glass House Brands Inc Graham Number

The Graham Number is not defined for negative earnings or book value. Guide · Calculator →

Healthcare · Drug Manufacturers - Specialty & Generic Long Beach, CA, US glasshousebrands.com

How the business is doing

Fiscal 2025–2025, USD

Revenue
$182T
20252025
Net income
-$-29.66T
20252025
Free cash flow
-$-15.73T
20252025
Total equity
$181.9T
20252021

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Financials

Statements by fiscal year

Fiscal 2025–2025, USD
FYFYFYFYFY
Revenue$182T————
Operating income-$-14.63T————
Net income-$-29.66T————
EPSd-$-361.98K————
Operating cash flow$11.4T————
Capital expenditure-$-27.18T————
Free cash flow-$-15.73T————
Total assets$318.6T$310.5T$303.8T$350.6T$287.6T
Total debt$74.6T$69.2T$75.1T$73.9T$48T
Net debt$54.7T$35.3T$45.6T$62.7T-$-3.08T
Total equity$82.1T$149.1T$130.2T$169.4T$181.9T
Cash and short-term investments$19.9T$33.9T$29.5T$11.1T$51.1T
Income statement
FY
Revenue$182T
Cost of revenue$105T
Gross profit$77T
Research and development expenses$0.00
Selling, general and administrative expenses$75.8T
Other expenses$15.8T
Operating expenses$91.6T
Cost and expenses$196.6T
Interest income$288B
Interest expense$7.06T
Depreciation and amortization$15.8T
Ebitda$5.8T
Operating income-$-14.63T
Total other income/expenses, net-$-2.39T
Income before tax-$-17.02T
Income tax expense$11.9T
Net income-$-29.66T
Weighted average shares outstanding$81.9T
Weighted average diluted shares outstanding$81.9T
Balance sheet
FYFYFYFYFY
Cash and short-term investments$19.9T$33.9T$29.5T$11.1T$51.1T
Net receivables$6.01T$7.15T$3.98T$6.04T$2.46T
Inventory$26.2T$14.3T$8.84T$11T$6.53T
Total current assets$67.7T$66.1T$49.2T$38.9T$68.6T
Property, plant and equipment, net$234.7T$223T$226.5T$227.6T$198.9T
Goodwill and intangible assets$11.6T$14.2T$21.2T$73.7T$10.5T
Long-term investments$0.00$2.34T$2.33T$4.25T$7.2T
Total non-current assets$250.8T$244.4T$254.6T$311.7T$219T
Total assets$318.6T$310.5T$303.8T$350.6T$287.6T
Accounts payable$13.7T$8.69T$5.54T$6.01T$4.34T
Short-term debt$1.99T$10.1T$9.39T$1.18T$307.1B
Deferred revenue$0.00$0.00$0.00$0.00$0.00
Total current liabilities$38T$66.5T$87.4T$54T$55.2T
Long-term debt$72.6T$59.1T$65.7T$72.7T$47.7T
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$198.5T$95T$86.2T$127.3T$50.4T
Capital lease obligations$5.91T$11T$11.1T$11.2T$3.13T
Total liabilities$236.5T$161.4T$173.5T$181.3T$105.6T
Common stock$0.00$0.00$0.00$0.00$0.00
Retained earnings-$-220.08T-$-190.42T-$-190.94T-$-92.67T-$-59.76T
Accumulated other comprehensive income (loss)$0.00$0.00$0.00$0.00$0.00
Total equity$82.1T$149.1T$130.2T$169.4T$181.9T
Total investments$0.00$2.34T$2.33T$4.25T$7.2T
Total debt$74.6T$69.2T$75.1T$73.9T$48T
Net debt$54.7T$35.3T$45.6T$62.7T-$-3.08T
Cash flow statement
FY
Net income-$-28.95T
Depreciation and amortization$15.8T
Stock-based compensation$13.4T
Change in working capital$2.5T
Accounts receivable$591B
Inventory-$-11.98T
Accounts payable$5.82T
Net cash provided by operating activities$11.4T
Investments in property, plant and equipment-$-27.18T
Acquisitions, net$0.00
Net cash used for investing activities-$-27.74T
Common stock issued$3.18T
Common stock repurchased-$-18.5T
Dividends paid-$-8.31T
Net cash used for financing activities$2.72T
Net change in cash-$-13.57T
Cash at end of period$23.4T
Operating cash flow$11.4T
Capital expenditure-$-27.18T
Free cash flow-$-15.73T
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Glass House Brands Inc

        Glass House Brands, Inc. operates as an integrated cannabis company in the United States with focus on the California market and building brands to serve consumers across various segments. The company is involved in greenhouse cultivation operations, manufacturing practices, brand-building, and retailing activities. The company offers its cannabis products through its portfolio of brands, which includes Glass House Farms, PLUS Products, Allswell, Forbidden Flowers, and Mama Sue Wellness. The company was founded by Kyle Kazan, Graham Farrar and Jocelyn Rosenwald in 2015 and is headquartered in Long Beach, CA.

        CEO
        Kyle Kazan
        Employees
        392
        Beta
        0.51

        Explore

        Frequently asked questions

        What is the intrinsic value of Glass House Brands Inc (GLAS)?

        InvestorsCraft does not currently publish an intrinsic value for GLAS. How the IC value is calculated.

        Is GLAS undervalued?

        InvestorsCraft does not publish an undervaluation signal for GLAS at this time.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Sep 19, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.